Product Launch

Modicare Limited announced the launch of ShiftLife Anti‑Spike Daily, a nutraceutical formulated with 250 mg of Reducose® (a patented white mulberry leaf extract) and chromium picolinate. The product was introduced in Delhi by Dr. Samir Kumar Modi, Founder & Managing Director of Modicare, and Mr. Wouter Claerhout, Vice President APAC of Phynova, the owner of the Reducose® technology.

Clinical Claim

Reducose® has been clinically studied and demonstrated reductions of up to 40 % in post‑meal glucose spikes under specific study conditions. The technology is also reported to moderate the insulin response to carbohydrate‑rich meals.

Additional Benefits (subject to substantiation)

The launch brochure lists five consumer benefits: up to 40 % smaller glucose spikes, a more moderated insulin response, reduced hunger with greater fullness, fewer sugar cravings, and more sustained energy. Benefits marked with an asterisk require applicable product‑claim substantiation in accordance with FSSAI regulations.

Product Positioning

Modicare positions the product as a science‑led approach to everyday metabolic wellness that fits modern Indian lifestyles without requiring consumers to forgo traditional foods such as parathas, dosas, biryani, and desserts.

Regulatory Disclaimer

ShiftLife Anti‑Spike Daily is a nutraceutical and is not intended to diagnose, treat, cure or prevent any disease. The up‑to‑40 % figure pertains to clinical findings for Reducose® under specific conditions and is not guaranteed for every consumer. Claims related to hunger, fullness, cravings and energy are subject to substantiation and compliance with FSSAI requirements. Consumers are advised to follow the product label and consult healthcare professionals where appropriate.

About Modicare

Established in 1996, Modicare Limited is an Indian direct‑selling company offering products across wellness, nutrition, personal care, skincare, home care and lifestyle categories, guided by its philosophy of Azadi.